Posted in | News | Nanobusiness

QD Vision and In-Q-Tel Expand Strategic Partnership

QD Vision, developer of nanotechnology-based solutions for displays and lighting, today announced a second technology advancement agreement with In-Q-Tel, the independent strategic investment firm that identifies innovative technology solutions to support the mission of the U.S. Intelligence Community. The agreement expands the range of technology being explored by QD Vision for the community.

QD Vision's Quantum Light™ platform uses quantum-dot technology to precisely tailor light emission in the near-infrared and visible spectrum, enabling the creation of any custom color when stimulated with photons or electrons. Leveraging a breakthrough portfolio of patents and pending applications from QD Vision and from MIT, the Quantum Light™ platform sets new standards for color purity and brightness, power efficiency and design versatility. QD Vision is currently bringing this technology to bear on a range of challenges in commercial markets such as consumer electronics and solid state lighting, as well as defense and security markets.

"QD Vision continues to deliver impressive technology capabilities," said Ben Levitan, Partner at In-Q-Tel. "QD Vision's technology offers great promise for cutting-edge nano-material applications for customers in both the government and commercial markets."

"As our partnership with In-Q-Tel unfolds, it is exciting to see multiple areas where our technology has the potential to meet the unique and demanding requirements of the Intelligence Community," said Dr. Dan Button, CEO of QD Vision. "Moreover, these developments for In-Q-Tel have considerable synergy with QD Vision's principal commercial agenda. We look forward to a long and productive working relationship with In-Q-Tel."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.